Dermatologic drug development involves the creation and testing of new medications specifically designed to treat a wide range of skin conditions, from common issues like acne and eczema to more complex diseases such as psoriasis and skin cancer. The process of developing dermatologic drugs requires a thorough understanding of skin biology, as well as how drugs interact with the skin's layers and systems. Advances in dermatologic drug development have led to targeted therapies, such as biologics and topical immunomodulators, which offer more precise and effective treatments with fewer side effects compared to traditional options. In addition to systemic treatments, innovations in drug delivery systems, such as nanoparticles and liposomes, are improving the effectiveness and penetration of topical treatments. Dermatologic drug development also focuses on personalized medicine, tailoring treatments to individual patients based on genetic, environmental, and lifestyle factors. As research progresses, new therapies continue to emerge, offering better management and potential cures for a range of dermatological diseases.
Sergei A Grando
University of California Irvine, United States
Gustavo Hector Leibaschoff
World Society of Cosmetic Gynecology, United States
Nalini Kaul
Princeton Consumer Research, Canada
Dechelette Corinne
La Peau Autrement, France
Rachita Dhurat
LTMMC & LTMG Hospital, India
Frederick H Silver
Robert Wood Johnson Medical School, Rutgers University, United States
Daan Thorn Leeson
Rodan + Fields, United States
Brannon Claytor
Claytor Noone Plastic Surgery, United States
Katie L Frederickson
Meharry Medical College, United States
Xiaozhun Hang
Queensland Institute of Medical Research Berghofer, AustraliaSubmit your abstract Today
Title : Integrating personalized and precision medicine into dermatology clinical practice securing ITS potential to get skin diseases cured and to revolutionize dermatology
Sergey Suchkov, National Center for Human Photosynthesis, Mexico
Title : Global perspectives on skin health: Diversity in dermatology and cosmetology
Dave Ray, Dave Ray Enterprises., United States
Title : How to correct cosmetic procedures gone wrong
Bharti Magoo, Golden Touch Clinic, India
Title : Epitomic analysis revealed pemphigus autoantibodies against the ligand-binding pocket of M3 muscarinic acetylcholine receptor
Sergei A Grando, University of California Irvine, United States
Title : Perspectives on healthy skin aging and pre-aging concepts
Georgios Stamatas, SGS France, France
Title : Efficacy and safety of rituximab versus pulse therapy in immunobullous disorders: A retrospective study
Ravi M Rathod, KMCRI, India
Title : Dermatology and cosmetology through art and history of art
Dechelette Corinne, La Peau Autrement, France
Title : Acne vulgaris and the most popular and new cosmetological treatments
Karolina Chilicka Hebel, University of Opole, Poland
Title : Stem cells in dermatology and cosmetology
Makoto Senoo, Cell Exosome Therapeutics Inc, Japan
Title : Standards, education and application of special cosmetic treatments in cosmetology practice
Elizabeta Popova Ramova, University MIT Skopje, Macedonia, The Former Yugoslav Republic of